share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Sep 18 04:15

Summary by Futu AI

Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company on 09/17/2024, with an aggregate market value of $78,332.78. The shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This upcoming transaction follows a series of sales over the past three months, where a total of 68,682 Class A shares were sold for gross proceeds of $520,914.92.
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company on 09/17/2024, with an aggregate market value of $78,332.78. The shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This upcoming transaction follows a series of sales over the past three months, where a total of 68,682 Class A shares were sold for gross proceeds of $520,914.92.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated